chitosan has been researched along with Anxiety Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, J; Baboota, S; Bari, NK; Fazil, M; Gaba, B; Haider, MR; Hassan, MQ; Narang, JK | 1 |
1 other study(ies) available for chitosan and Anxiety Disorders
| Article | Year |
|---|---|
Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.
Topics: Administration, Intranasal; Animals; Anti-Anxiety Agents; Anxiety Disorders; Biological Availability; Brain; Buspirone; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Liberation; Maze Learning; Molecular Structure; Nanoparticles; Particle Size; Permeability; Rats; Serotonin Receptor Agonists; Spectroscopy, Fourier Transform Infrared; Swine; X-Ray Diffraction | 2015 |